Please ensure Javascript is enabled for purposes of website accessibility

No Hooray for Accuray in Q4

By Keith Speights – Aug 16, 2019 at 6:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CyberKnife maker missed Wall Street bottom-line estimates and announced disappointing guidance for fiscal 2020.

Accuray (ARAY -3.76%) got off to a great start in 2019, jumping more than 50% earlier in the year after posting a lower-than-expected net loss and strong growth in orders. However, the picture hasn't been as bright since the first quarter, with Accuray's shares giving up all of the gains.

The CyberKnife maker announced its fourth-quarter results after the market closed on Thursday. Investors weren't pleased, with shares falling more than 8% in after-hours trading. Here's what you need to know about Accuray's Q4 update.

A woman sitting in a wheelchair, smiling with her arms outstretched.

Image source: Getty Images.

By the numbers

Accuray announced Q4 revenue of $117.4 million, a 3% increase from the $113.8 million reported in the same quarter of the previous year. The result was also slightly higher than the average analysts' revenue estimate of $116.4 million.

The company reported a net loss in the fourth quarter of $1.4 million, or $0.02 per share, based on generally accepted accounting principles (GAAP). Accuray's bottom line reflected deterioration from the prior-year-period GAAP net loss of $900,000, or $0.01 per share. It was also worse than the Wall Street estimate for a net loss in Q4 of $0.01.

Accuray ended the fourth quarter with cash, cash equivalents, and short-term investments of $87 million. This was an increase of $22.4 million from the company's cash position as of March 31, 2019.

Behind the numbers

The numbers themselves don't reveal that this was Accuray's highest quarterly revenue in the company's history. Although service revenue slipped to $56.8 million from $59.2 million in the prior-year period, Accuray's product sales more than offset that decline. The company stated that product revenue in the fourth quarter totaled $60.6 million, up from $54.6 million in the fourth quarter of fiscal 2018.

Despite this revenue performance, though, Accuray's bottom line worsened for a couple of key reasons. First, the company's gross margin fell from 42.2% in the prior-year period to 39.1% in the fourth quarter of fiscal 2019. Second, Accuray experienced a bigger hit from income taxes in the quarter and had an income tax benefit in the year-ago period.

The company reported that its gross product orders increased slightly year over year to $97.2 million. Its order backlog at the end of the fourth quarter stood at $495.6 million, up 4% year over year.

In addition to its financial results, Accuray highlighted a couple of major milestones achieved in the fourth quarter. The company signed its first multisystem order bundling with RaySearch Laboratories for products and software offerings. It also signed the first upgrade order for its Radixact correction technology's Synchrony motion tracking.

Looking ahead

Accuray projects full-year fiscal 2020 sales will be between $410 million and $420 million. This range includes the impact of Chinese tariffs that are currently in place. Revenue in the first half of the year will be a little lower than fiscal 2019 levels due to the anticipated delay in the timing of Class A system revenue.

The company also expects adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) will be between $19 million and $24 million. This includes a loss of around $2 million from Accuray's China joint venture.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Accuray Stock Quote
Accuray
ARAY
$2.05 (-3.76%) $0.08

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.